Original Research
Published on 26 Aug 2022
Olaparib, a PARP-1 inhibitor, protects retinal cells from ocular hypertension-associated oxidative damage
in Molecular and Cellular Pathology
- 6,014 views
- 7 citations
Original Research
Published on 26 Aug 2022
in Molecular and Cellular Pathology
Original Research
Published on 26 Aug 2022
in Molecular and Cellular Pathology
Mini Review
Published on 26 Aug 2022
in Molecular and Cellular Pathology
Original Research
Published on 25 Aug 2022
in Molecular and Cellular Pathology
Editorial
Published on 25 Aug 2022
in Molecular and Cellular Pathology
Mini Review
Published on 24 Aug 2022
in Molecular and Cellular Pathology
Original Research
Published on 23 Aug 2022
in Molecular and Cellular Pathology
Editorial
Published on 22 Aug 2022
in Molecular and Cellular Pathology
Original Research
Published on 16 Aug 2022
in Molecular and Cellular Pathology
Original Research
Published on 16 Aug 2022
in Molecular and Cellular Pathology
Original Research
Published on 16 Aug 2022
in Molecular and Cellular Pathology
Original Research
Published on 15 Aug 2022
in Molecular and Cellular Pathology
Review
Published on 15 Aug 2022
in Molecular and Cellular Pathology
Review
Published on 12 Aug 2022
in Molecular and Cellular Pathology
Original Research
Published on 12 Aug 2022
in Molecular and Cellular Pathology
Original Research
Published on 12 Aug 2022
in Molecular and Cellular Pathology